% Expired Patents = 25.0

EPO Patents = 1

Trademarks = 1

Forward Citations = 55

Loading Chart...

4 inventors (with patents filed for the assignee):

John C Gerdes (2 out of 19 patents)

Jeffrey M Marmaro (1 out of 12 patents)

Duane E Day (1 out of 1 patent)

4. Duane D Day (1 out of 1 patent)

5. Duane Ellington Day (0 patent)

4 patents: Sort by Forward Citations

1. 9085795 - Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies (2015-07-21),

2. 7015021 - Method for making purified plasminogen activator-inhibitor type 1 (PAI-1) and purified PAI-1 made therefrom (2006-03-21),

3. 6063568 - Quantitation of RNA transcripts using genomic DNA as the internal (2000-05-16),

4. 5989813 - Detection of amplified nucleic acid sequences using bifunctional (1999-11-23),

Company Overview

Molecular Innovations, Inc. is a leading provider of high-quality antibodies, proteins, and ELISA kits for life science research. With over 20 years of experience, we offer innovative products for immunology, cell biology, and neuroscience research. Our products are trusted by researchers worldwide for their reliability and accuracy in a wide range of applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#33 in Novi, MI

#2,021 in Michigan

#60,597 in US

Novi, MI, United States of America

Molecular Innovations, Inc.

Forward Citations = 55

4 inventors:

John C Gerdes (2 out of 19 patents)

Jeffrey M Marmaro (1 out of 12 patents)

Duane E Day (1 out of 1 patent)

4. Duane D Day (1 out of 1 patent)

5. Duane Ellington Day (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Molecular Innovations, Inc.. Retrieved from https://idiyas.com/company/molecular-innovations

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]